Chapter 9, Problem 9.11AC

I got stuck on this question of null hypothesis

Trichotillomania is an illness characterized by the repeated urge to tear out hair, eyelashes, facial hair, nose hair, pubic hair, eyebrows, or other body hair, sometimes resulting in noticeable bald patches. A pharmaceutical company is trying to decide whether to market a drug to treat trichotillomania. The pharmacist who designed the drug believes it is very effective, especially when combined with therapy, whereas a researcher who did research on a sample of people suffering from the disorder is less convinced. Each of them created graphs to support his or her position.              Determine whether the pharmacist or the researcher created each graph. (Hint: Decide whether the graph minimizes or maximizes the effect of the drug first. Then decide who would want to do that, and choose your response from the list of possible combinations.)

Many consumer groups feel that the U.S. Food and Drug Administration (FDA) drug approval process is too easy and, as a result, too many drugs are approved that are later found to be unsafe. On the other hand, a number of industry lobbyists have pushed for a more lenient approval process so that pharmaceutical companies can get new drugs approved more easily and quickly. The FDA wants to set up a hypothesis test to show that the new drug is safe before approving it by assuming it to be unsafe.   Match the followings concepts to their correct interpretations in the context of the question:                                                             Null hypothesis                                                             Alternative hypothesis                                                             Type I error                                                             Type II error A. The new drug is unsafe but the FDA concludes that it is…